D’Souza, M.; Bagger, M.; Alberti, M.; Malmborg, M.; Schou, M.; Torp-Pedersen, C.; Gislason, G.; Svane, I.M.; Kiilgaard, J.F.
Immune Checkpoint Inhibitor Treatment and Ophthalmologist Consultations in Patients with Malignant Melanoma or Lung Cancer—A Nationwide Cohort Study. Cancers 2022, 14, 49.
https://doi.org/10.3390/cancers14010049
AMA Style
D’Souza M, Bagger M, Alberti M, Malmborg M, Schou M, Torp-Pedersen C, Gislason G, Svane IM, Kiilgaard JF.
Immune Checkpoint Inhibitor Treatment and Ophthalmologist Consultations in Patients with Malignant Melanoma or Lung Cancer—A Nationwide Cohort Study. Cancers. 2022; 14(1):49.
https://doi.org/10.3390/cancers14010049
Chicago/Turabian Style
D’Souza, Maria, Mette Bagger, Mark Alberti, Morten Malmborg, Morten Schou, Christian Torp-Pedersen, Gunnar Gislason, Inge Marie Svane, and Jens Folke Kiilgaard.
2022. "Immune Checkpoint Inhibitor Treatment and Ophthalmologist Consultations in Patients with Malignant Melanoma or Lung Cancer—A Nationwide Cohort Study" Cancers 14, no. 1: 49.
https://doi.org/10.3390/cancers14010049
APA Style
D’Souza, M., Bagger, M., Alberti, M., Malmborg, M., Schou, M., Torp-Pedersen, C., Gislason, G., Svane, I. M., & Kiilgaard, J. F.
(2022). Immune Checkpoint Inhibitor Treatment and Ophthalmologist Consultations in Patients with Malignant Melanoma or Lung Cancer—A Nationwide Cohort Study. Cancers, 14(1), 49.
https://doi.org/10.3390/cancers14010049